Akums launches novel formulations for patients with gastrointestinal disorders in India – Healthcare News

Akums Drugs & Pharmaceuticals Ltd. on Monday announced that it has launched Rabeprazole + Levosulpiride SR Capsules. Approved by the Drug Controller General of India (DCGI), the company claims this new formulation aims to enhance relief for patients suffering from gastrointestinal tract (GIT) disorders.

GERD, or gastro-oesophageal reflux disease, is a debilitating condition characterised by the reflux of stomach contents into the oesophagus, leading to troublesome symptoms and potential complications. With GERD often dubbed as chronic acid reflux, its prolonged presence not only impacts the quality of life but also poses risks of serious health complications, including stomach and esophageal cancer.

“Rabeprazole sodium, a potent antisecretory compound, selectively inhibits gastric acid secretion by targeting the H+ and K+ ATPase at the surface of gastric parietal cells. It has demonstrated efficacy in treating gastric and duodenal ulcers, as well as GERD. Complementing rabeprazole, Levosulpiride, the levo-enantiomer of sulpiride, exhibits significant central antidopaminergic activity and antiemetic effects,” the company said in a statement.

Prostate cancer, abdominal surgery, intestines, medical case, rare medical cases, bizarre medical cases, healthcare news,

Man’s intestines fall out while he was having breakfast at a restaurant—Read on to know what exactly happened

New fungal infection, Sexually transmitted diseases, Ringworm, fungal ringworm, STDs, ringworm in New York, Healthcare News,

Rare, highly contagious sexually transmitted fungal infection detected in New York—Here’s what you should know

Pregnancy, pregnant women, women's health, women's depression, health news, wellness news, healthtech news,

THIS app can predict depression among pregnant women; Here’s how

Bharat Biotech, Covaxin, Covaxin side effects, Covaxin adverse effects, Bharat Biotech's vaccine, Coronavirus, Coronavirus vaccine, Covid-19, Covid, Covid vaccine, vaccine side effects, Astrazeneca, Covishield, Covishield row, Astrazeneca's vaccine, Covishield side effects

Covaxin side-effects: Over 30 percent recipients suffered from adverse effects of vaccine; Should you be worried?

Its peripheral anti-dopaminergic action modulates the motor activity of the upper digestive tract, making it valuable in gastro-enterology, it claimed.

“We are excited to introduce a solution for patients suffering from GERD and related gastrointestinal disorders. GERD diagnosis and treatment rely on symptom management and acid suppression therapies. Our Rabeprazole + Levosulpiride SR Capsules aim to offer an effective remedy, ease symptoms, enhance gastrointestinal function, and boost patients’ overall well-being. Levosulpiride offers rapid relief and better healing outcomes with fewer side effects, elevating the overall treatment experience,” Arushi Jain, Director, Akums Drugs & Pharmaceuticals Ltd. said in a statement.

Each hard gelatin capsule contains Rabeprazole Sodium IP 40 mg (as enteric-coated form) and Levosulpiride 75 mg (as uncoated sustained-release form). The recommended dosage is one capsule once daily or as directed by a physician.


Leave a Reply

Your email address will not be published. Required fields are marked *